Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-DRB1 polymorphism is associated with Kell immunisation.

Jacques Chiaroni1, Isabelle Dettori, Virginie Ferrera

  • 1EFS Alpes-Méditerranée, Biology, Marseille, France. jacques.chiaroni@efs.sante.fr

British Journal of Haematology
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The RHCE*CeRN allele: molecular junction characterization and frequency distribution in Sub-Saharan African populations.

Blood transfusion = Trasfusione del sangue·2026
Same author

Reply to "Biological variation of serum cholinesterase activity in healthy subjects": analytical validation of cholinesterase activity measurement in routine practice: experience from a French clinical laboratory.

Clinical chemistry and laboratory medicine·2026
Same author

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.

Annals of hematology·2025
Same author

HLA Class Ib and MICA/MICB Expression in Human Tissues and Cell Types: Reshuffling Immune Players.

HLA·2025
Same author

Enhanced vestibular-evoked balance responses in adolescents with idiopathic scoliosis.

Journal of neurophysiology·2025
Same author

Red blood cell alloimmunization immunogenetic risk factor.

Current opinion in immunology·2025
Same journal

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromes.

British journal of haematology·2026
Same journal

Author response to Zhang and Chen.

British journal of haematology·2026
Same journal

Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

British journal of haematology·2026
Same journal

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

British journal of haematology·2026
See all related articles

Genetic background influences Kell (K) antigen immunization. Specific HLA-DRB1 alleles, particularly HLA-DRB1*11 and HLA-DRB1*13, are significantly more frequent in immunized individuals, suggesting a role in K peptide presentation.

Area of Science:

  • Immunogenetics
  • Transfusion Medicine
  • Molecular Anthropology

Background:

  • Kell (K) antigen immunization occurs in some, but not all, cases of K incompatibility.
  • Genetic factors likely contribute to the selective immune response to K antigen.

Purpose of the Study:

  • To investigate the association between specific Human Leukocyte Antigen - DRB1 (HLA-DRB1) alleles and K immunization.
  • To explore the role of genetic background in selective K antigen immune responses.

Main Methods:

  • HLA-DRB1 genotyping using polymerase chain reaction sequence-specific oligonucleotide/sequence-specific primer methods.
  • Comparison of allele frequencies between 54 K-immunized patients and 200 healthy controls from a southern European population.

Main Results:

Related Experiment Videos

  • A significantly higher frequency of HLA-DRB1*11 was observed in K-immunized patients (57%) compared to controls (28%).
  • Among HLA-DRB1*11-negative patients, HLA-DRB1*13 was also more frequent (61%) than in controls (34%).
  • The combined frequency of HLA-DRB1*11 and HLA-DRB1*13 was 83% in immunized patients versus 52% in controls.

Conclusions:

  • Specific HLA-DRB1 alleles (HLA-DRB1*11 and HLA-DRB1*13) are strongly associated with K immunization in this population.
  • Shared structural features of these alleles may facilitate specific K peptide presentation by HLA-DR molecules, influencing immune response.